Infiltrative cardiovascular diseases: cardiomyopathies that look alike
- PMID: 20413025
- DOI: 10.1016/j.jacc.2009.12.040
Infiltrative cardiovascular diseases: cardiomyopathies that look alike
Abstract
Infiltrative cardiomyopathies are characterized by the deposition of abnormal substances that cause the ventricular walls to become progressively rigid, thereby impeding ventricular filling. Some infiltrative cardiac diseases increase ventricular wall thickness, while others cause chamber enlargement with secondary wall thinning. Increased wall thickness, small ventricular volume, and occasional dynamic left ventricular outflow obstruction (e.g., amyloidosis) can outwardly appear similar to conditions with true myocyte hypertrophy (e.g., hypertrophic cardiomyopathy, hypertensive heart disease). Likewise, infiltrative disease that presents with a dilated left ventricle with global or regional wall motion abnormalities and aneurysm formation (e.g., sarcoidosis) may mimic ischemic cardiomyopathy. Low-voltage QRS complex was the sine qua non of infiltrative cardiomyopathy (i.e., cardiac amyloid). However, low-voltage QRS complex is not a uniform finding with the infiltrative cardiomyopathies. The clinical presentation, along with functional and morphologic features, often provides enough insight to establish a working diagnosis. In most circumstances, however, tissue or serologic evaluation is needed to validate or clarify the cardiac diagnosis and institute appropriate therapy.
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
[Cardiac amyloidosis. Invasive and noninvasive diagnosis].G Ital Cardiol. 1987 Dec;17(12):1016-30. G Ital Cardiol. 1987. PMID: 3503797 Italian.
-
Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.Acta Med Scand. 1987;221(1):39-46. Acta Med Scand. 1987. PMID: 3565084
-
[Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].Rofo. 2007 Jan;179(1):21-30. doi: 10.1055/s-2006-927204. Rofo. 2007. PMID: 17203440 Review. German.
-
MR imaging of cardiomyopathy.Magn Reson Imaging Clin N Am. 1996 May;4(2):269-86. Magn Reson Imaging Clin N Am. 1996. PMID: 8724566 Review.
-
[Reliability and limitation of various diagnostic methods including nuclear medicine in myocardial disease (author's transl)].J Cardiogr. 1981 Dec;11(4):1113-25. J Cardiogr. 1981. PMID: 7201492 Japanese.
Cited by
-
Classification of Infiltrative Heart Diseases MORAL-STAGE System.Clin Med Insights Cardiol. 2024 Oct 1;18:11795468241249075. doi: 10.1177/11795468241249075. eCollection 2024. Clin Med Insights Cardiol. 2024. PMID: 39484204 Free PMC article.
-
Fabry Disease Cardiomyopathy: A Review of the Role of Cardiac Imaging from Diagnosis to Treatment.Rev Cardiovasc Med. 2022 May 27;23(6):192. doi: 10.31083/j.rcm2306192. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077169 Free PMC article. Review.
-
Hypertrophy cardiomyopathy: A case of infantile-onset Pompe disease in cardiac magnetic resonance findings.Heliyon. 2023 Jul 17;9(7):e18330. doi: 10.1016/j.heliyon.2023.e18330. eCollection 2023 Jul. Heliyon. 2023. PMID: 37539106 Free PMC article.
-
Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography.Front Cardiovasc Med. 2023 Jul 3;10:1183485. doi: 10.3389/fcvm.2023.1183485. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37465456 Free PMC article.
-
Amyloidosis: What does pathology offer? The evolving field of tissue biopsy.Front Cardiovasc Med. 2022 Dec 5;9:1081098. doi: 10.3389/fcvm.2022.1081098. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36545023 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
